Current Medical Research and Opinion

Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London
pp. 1891-1894(4)
Authors: Moniz, C.; Dew, T.; Dixon, T.

Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)
pp. 1895-1903(9)
Authors: Emkey, Ronald; Koltun, William; Beusterien, Kathleen; Seidman, Larry; Kivitz, Alan; Devas, Vipul; Masanauskaite, Daiva

Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population
pp. 1905-1913(9)
Authors: Currie, Craig J.; McEwan, Phil; Emmas, Cathy; Morgan, Christopher L.l.; Peters, John R.

Short-term economic impact associated with occupational needlestick injuries among acute care nurses
pp. 1915-1922(8)
Authors: Lee, Won Chan; Nicklasson, Lars; Cobden, David; Chen, Er; Conway, Donald; Pashos, Chris L.

Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections
pp. 1923-1926(4)
Authors: Finney, Michael S.; Crank, Christopher W.; Segreti, John

High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients
pp. 1927-1934(8)
Authors: Bruckert, Eric; Baccara-Dinet, Marie; McCoy, Fran; Chapman, John

Short and longer term outcomes of a diabetes disease management program in underserved Latino patients
pp. 1935-1941(7)
Authors: Mathur, Ruchi; Roybal, G. Michael; Peters, Anne L.

Influence of switching to travoprost on intraocular pressure of uncontrolled chronic open-angle glaucoma patients compliant to previously-used topical medication
pp. 1943-1948(6)
Authors: Holló, Gábor; Vargha, Péter; Kóthy, Péter

Efficacy of a new aluminium salt thermophobic foam in the treatment of axillary and palmar primary hyperhidrosis: a pilot exploratory trial
pp. 1949-1953(5)
Authors: Innocenzi, Daniele; Lupi, Francesca; Bruni, Francesca; Frasca, Mirko; Panetta, Chiara; Milani, Massimo

The effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: a secondary analysis of the MORE trial
pp. 1955-1959(5)
Authors: Qu, Yongming; Wong, Mayme; Thiebaud, Daniel; Stock, John L.

Evaluation of the bioequivalence of two transdermal fentanyl systems following single and repeat applications
pp. 1961-1968(8)
Authors: Sathyan, Gayatri; Guo, Cindy; Sivakumar, Krishna; Gidwani, Shalini; Gupta, Suneel

Comparative characterisation of a commercial human chorionic gonadotrophin extracted from human urine with a commercial recombinant human chorionic gonadotrophin
pp. 1969-1976(8)
Authors: Bassett, R.; De Bellis, C.; Chiacchiarini, L.; Mendola, D.; Micangeli, E.; Minari, K.; Grimaldi, L.; Mancinelli, M.; Mastrangeli, R.; Bucci, R.

Predictors of high-cost managed care patients with acute coronary syndrome
pp. 1977-1984(8)
Authors: Etemad, Lida R.; McCollam, Patrick L.

Extended adjuvant endocrine therapy of early breast cancer
pp. 1985-1995(11)
Authors: Chowdhury, Simon; Ellis, Paul

Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study
pp. 1997-2006(10)
Authors: Filippatos, T.D.; Kiortsis, D.N.; Liberopoulos, E.N.; Georgoula, M.; Mikhailidis, D.P.; Elisaf, M.S.

Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension
pp. 2007-2016(10)
Authors: Narine, L.; Hague, L.K.; Walker, J.H.; Vicente, C.; Schilz, R.; Desjardins, O.; Einarson, T.R.; Iskedjian, M.

The economic burden of schizophrenia in Canada in 2004
pp. 2017-2028(12)
Authors: Goeree, R.; Farahati, F.; Burke, N.; Blackhouse, G.; O'Reilly, D.; Pyne, J.; Tarride, J.E.

Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study
pp. 2029-2035(7)
Authors: Weissman, P.; Goldstein, B.J.; Rosenstock, J.; Waterhouse, B.; Cobitz, A.R.; Wooddell, M.J.; Strow, L.J.

Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study
pp. 2037-2049(13)
Authors: Zerbini, C.; Ozturk, Z.E.; Grifka, J.; Maini, M.; Nilganuwong, S.; Morales, R.; Hupli, M.; Shivaprakash, M.; Giezek, H.; The Etoricoxib CLBP Study Group,

A cost-utility analysis of low-dose hormone replacement therapy in postmenopausal women with an intact uterus
pp. 2051-2061(11)
Authors: Swift, James A.; Conway, Peter; Purdie, David W.

Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting
pp. 2063-2071(9)
Authors: Valentine, William J.; Palmer, Andrew J.; Lammert, Morten; Nicklasson, Lars; Foos, Volker; Roze, Stéphane